United States · FDA National Drug Code directory
Praluent
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0024-5901_fba901c3-f56a-4d92-9e68-d1eac9aed031
- Product NDC
- 0024-5901
- Form
- INJECTION, SOLUTION
- Composition / generic term
- alirocumab
- Labeler
- Sanofi-Aventis U.S. LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 20150724
- Source listing expiry
- 20271231
Source-listed ingredients
- ALIROCUMAB — 75 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (0024-5901-00) / 1 mL in 1 SYRINGE, GLASS · 0024-5901-00
- 1 SYRINGE, GLASS in 1 CARTON (0024-5901-01) / 1 mL in 1 SYRINGE, GLASS · 0024-5901-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →